A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LPR / late-phase response

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LPR  (>> Co-occurring Abbreviation)
Long Form:   late-phase response
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: Arandomized controlled trial. SCIT
2012 The brain and asthma: what are the linkages?. fMRI
2009 Antiallergic activity of unripe Citrus hassaku fruits extract and its flavanone glycosides on chemical substance-induced dermatitis in mice. IPR, PC-CD, SC, vLPR
2008 Histamine release inhibitory activity of Piper nigrum leaf. DNFB, DNP, IPR, p.o, PC, vLPR
2008 Ovalbumin-sensitized mice are good models for airway hyperresponsiveness but not acute physiological responses to allergen inhalation. AHR, BAL, EPR, LFOT, OVA
2006 A late cutaneous response in actively sensitized rats: a new method for evaluating the efficacy of antiallergic drugs. DNP-OA, EPR
2005 [Effect of cetirizine hydrochloride on the expression of substance P in IgE-mediated triphasic cutaneous reaction]. DNFB, IPR, RIA, SP, vLPR
2003 Increased circulating FcepsilonRII-bearing B-lymphocytes and serum levels of IL-4 in non-autoreactive chronic idiopathic urticaria. CIU, EASIA, ELFA
2001 A Kampo formulation: Byakko-ka-ninjin-to (Bai-Hu-Jia-Ren-Sheng-Tang) inhibits IgE-mediated triphasic skin reaction in mice: the role of its constituents in expression of the efficacy. IPR, vLPR
10  2001 Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. VIT
11  2001 Involvement of neuropeptides in the allergic nasal obstruction in guinea pigs. CGRP, EPR, NKA, SP
12  2001 Late phase responses after nasal challenges with allergen and histamine in asthmatic children with perennial nasal allergy. ---
13  2000 Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients. A-BPT, AA, AR, BHR, IL, MRP
14  2000 Differential effect of antiallergic drugs on IgE-mediated cutaneous reaction in passively sensitized mice. anti-DNP, DNFB, IPR, PAF
15  2000 Nitric oxide is a mediator of the late-phase response in an animal model of nasal allergy. NO
16  1999 Effect of Shimotsu-to (a Kampo medicine, Si-Wu-Tang) and its constituents on triphasic skin reaction in passively sensitized mice. IPR, vLPR
17  1999 Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. BEC, EIB, IL-8, MAP
18  1998 Late phase response in nasal mucosa closely correlated with immediate phase reaction and hyperreactivity to histamine. IR, NAR
19  1997 The inhibitory effect of anti-adhesion molecule antibodies on eosinophil infiltration in cutaneous late phase response in Balb/c mice sensitized with ovalbumin (OVA). ICAM-1, LFA-1, mAb, Mac-1, OVA, VCAM-1, VLA-4
20  1997 [The inhibitory effect of LTB4 antagonist on eosinophil infiltration in cutaneous and gut late phase response in BALB/C mice sensitized with ovalubumin (OVA)]. OVA
21  1996 Effect of benzodiazepine on antigen-induced eosinophil infiltration into guinea pig conjunctiva. BZP, EPR, i.p, OVA, PAF
22  1996 Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. ECP
23  1994 Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. DTH, IL
24  1994 The effect of immunotherapy on the cutaneous late phase response to antigen. IT
25  1993 Cutaneous late-phase response in food-allergic children and adolescents with atopic dermatitis. AD
26  1992 Antigen-induced acute and late-phase responses in primates. ---
27  1992 Effect of dietary fish oil supplementation on the antigen-induced late-phase response in the skin. ---
28  1992 Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. ELISA, IL-1, IL-6
29  1992 Use of cetirizine to investigate non-H1 effects of second-generation antihistamines. PAF
30  1991 Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. LTC4
31  1991 [The study of chemical mediators in the patients with allergic rhinitis 2). Histamine, leukotriene and kinins in the nasal secretion during dual phase response]. EPR, LT, NAR
32  1990 [Current pathophysiologic aspects of allergic rhinitis. I]. ---
33  1989 Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. PGD2
34  1989 Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. BAL, LT, SER
35  1989 The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). LTC4
36  1988 Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. ---
37  1987 Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Ag, BAL, Dil, SER
38  1986 Cutaneous mast cell heterogeneity: response to antigen in atopic dogs. MCs
39  1986 IgE antibody mediated inflammation of rat lung: histologic and bronchoalveolar lavage assessment. BAL, DNP, OA, PMNs
40  1985 Effect of betamethasone on the dual reaction to anti-human IgE in man: influence of time interval between administration of drug and anti-IgE. ID